About Kinaset Therapeutics
Kinaset Therapeutics is a private company based in Medfield, Massachusetts, incorporated in 2020 in Delaware. It has reported $30,000,000 raised in two offerings on Form D since August 2020. Its chief executive is Robert Clarke.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 5, 2022 | Jul 18, 2022amended Jul 17, 2023 | $28,500,000of $41.0M target | 3 | $9.5M | Equity, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Jul 31, 2020 | Aug 17, 2020 | $1,500,000of $40.0M target | 3 | $500K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $30,000,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Kinaset Therapeutics's Form D filed Jul 17, 2023.
TK
Tom King
Director
JB
RC
Robert Clarke
Chief Executive Officer and director
BV
Bram Vanparys
Director
FM
Frazer Morgan
Chief Development Officer
KB
Kevin Bitterman
Director
RH
Roger Heerman
Chief Business Officer and Chief Operating Officer